A randomized, double-blind, single-dose, single-center, parallel phase I clinical study comparing the pharmacokinetics, immunogenicity, safety, and tolerance of pertuzumab injection and Perjeta® in healthy Chinese male subjects
暂无分享,去创建一个
Yanli Wang | Zeyu Wang | Xin-Ning Qu | Wei H. Yang | Tianying Chang | Q. Ren | Yingzi Cui | Guang-ping Liu | Jinling Xue | Zhengzhi Liu | Qiaohuan Deng | Haimiao Yang | Zhongnan Xu | Jiahui Chen | Wanhua Wang | Yang Cheng | Shuang Yu | Yannan Zhou